Seventeen commercially available jet nebulizers from 15 commercial sources were studied (Acorn-I, Acorn-II, AquaTower, AVA-NEB, Cirrhus, Dart, DeVilbiss 646, Downdraft, Fan Jet, MB-5, Misty Neb, PARI LC JET, PARI-JET, Salter 8900, Sidestream, Updraft-II, Whisper Jet). All nebulizers were filled with 2 ml of saline solution plus 0.5 ml of albuterol and powered with the same source (DeVilbiss PulmoAide). We compared total output (TO), time for total output (TTO), and percent output in respirable range (PORR). The TO was obtained by weighing before nebulization and at the point of eightfold decline in output. The ITO was calculated from initiation of nebulization to the point of eightfold decline in output. The PORR was measured by a laser particle analyzer in continuous nebulization to Health Care, Somerset, Pa), MB-5 (Mefar, Bovezzo, Italy), Misty Neb (Baxter, Valencia, Calif), PARI LC JET and PARI-JET (PARI Respiratory, Richmond, Va), Salter 8900 (Salter Labs, Arvin, Calif), and the Sidestream (Inspired Medical Products, Hopkinton, Mass). The nebulizers were studied using four units of each model, each run three times to determine intramodel and intermodel variability. All nebulizers studied were available in the United States. All were purchased through normal procurement channels to preclude special pretesting. All models were represented by the manufacturer to be reusable.
Seventeen commercially available jet nebulizers from 15 commercial sources were studied (Acorn-I, Acorn-II, AquaTower, AVA-NEB, Cirrhus, Dart, DeVilbiss 646, Downdraft, Fan Jet, MB-5, Misty Neb, PARI LC JET, PARI-JET, Salter 8900, Sidestream, Updraft-II, Whisper Jet). All nebulizers were filled with 2 ml of saline solution plus 0.5 ml of albuterol and powered with the same source (DeVilbiss PulmoAide). We compared total output (TO), time for total output (TTO), and percent output in respirable range (PORR). The TO was obtained by weighing before nebulization and at the point of eightfold decline in output. The ITO was calculated from initiation of nebulization to the point of eightfold decline in output. The PORR was measured by a laser particle analyzer in continuous nebulization to the same point of abrupt drop in output. The TO varied from 0.98 To 1.86 ml (p<0.0001) with the Acorn-I, Acorn-TI, Updraft-II, and Sidestream, significantly greater than the others (p<0.05). The TTO varied from 2.28 to 20.95 min (p<0.0001). The AquaTower, PARI LC JET and PARI-JET, DeVilbiss, and Dart were significantly shorter than the others (p<0.05). The PORR varied from 21.89 to 71.95 percent (p<0.0001). The Sidestream was significantly greater than all others (p<0.05). The PARI T nhaled medications for the treatment of asthma have become the mainstay of therapy. The principal means use to deliver inhaled particles are through jet nebulizers and fluorocarbon metereddose inhalers (MDI) . While the MDls are more convenient,1 they cannot be used by young children and present problems to some individuals of all ages. . The nebulizers were studied using four units of each model, each run three times to determine intramodel and intermodel variability. All nebulizers studied were available in the United States. All were purchased through normal procurement channels to preclude special pretesting. All models were represented by the manufacturer to be reusable.
Volume Fill
Each nebulizer was filled with 2 ml of normal saline solution and 0.5 ml of albuterol (Proventil Nebulizer Solution, Schering Corp, Kenilworth, NJ). The initial and final weights were precisely determined on a balance (OHAUS Scale Corp, Florham Park, NJ).
Testing Conditions
The driving pressure for the nebulizers was supplied by a compressor (DeVilbiss PulmoAide 5610D, DeVilbiss Health Care, Somerset, Pa) at ambient conditions, temperature of 20 to 23.8°C (68 to 75°F) relative humidity of 20 to 54 percent, and an elevation of 1.6 km (5,280 feet). This compressor, when not attached to a nebulizer, was determined to have a gas flow rate of 12.3 standard liters per minute. Nebulizer units were tested in random order.
Aerosol Characterization
The nebulizers were analyzed continuously with a high-volume scattering aerosol spectrometry probe (model CSASP-100, PMS, Boulder, Colo). The aerosol was analyzed for particles in the range of 0.5 to 32 pm. In this device, particles pass through a laser beam and the light bent or refracted. Larger particles refract light at a greater angle and particles are sized by their angle of refraction. When two particles pass through the laser beam at the same time or when a particle does not pass completely through the beam, the analyzer detects these events and excludes these data from calculation.
The probe was adapted for wet aerosol measurement with a separation device, employing the same negative pressure, which diverted part of the aerosol cloud to preclude overload with coincidence and oversizing of particles. Both the diverter and the suction system connected to the probe allowed for a flow rate of 16 L/min.
The suction accelerates particles through a parabolic horn and then through the sampling zone containing the laser. Sampling was performed over three different size ranges sequentially at an interval of 2 s. This allowed a complete measurement of the entire range every 6 s. Each of the three ranges of analysis contained 15 channels of increasing incremental size (0.5 to 8.0 ,um at 0.5-pm increments; 1.0 to 16.0 pm at 1.0-prm increments, and 2.0 to 32.0 pum at 2.0-,m increments). There was overlap among ranges with the 0.5-pum increments being the most precise. A computer program automatically discarded the values from the channels in each range that overlapped with a more precise channel. This program also scaled the values from each range to 1.0-pm increments so that comparisons between ranges could be easily plotted. The The results are summarized graphically using diamond plots, which are in the means and 95 percent confidence intervals about the means using a pooled estimate of the variance. All analyses were performed (using JMP Version 2.0.5) on a personal computer (Apple Quadra 700).
RESULTS
The results of the triplicate runs for four units of each of 17 models of jet nebulizers are summarized in Figures 1 through 4 . Volume The TO to the point of eightfold decline in particle output for each of the 17 models of jet nebulizers is shown in Figure 1 . Overall, both the means and variances were significantly different (p<0.0001 for each). The TO varied from 0.98 ml (Aquatower) to 1.86 ml (Sidestream). The TO of the Sidestream (1.86 ml) was significantly greater than all the others (p<0.05) and the TO of the Acorn 1 (1.63 ml), Acorn 11 (1.61 ml), and the Updraft 11 (1.62 ml) were significantly greater than the remainder (p<0.05). The TO from individual units of the AquaTower greatly varied.
Time
The time to the point of eightfold drop in particle output is shown in Figure 2 
Percent of Particles in Respirable Range
The PORR is shown in Figure 3 . There was a highly significant difference in the means and variances among the devices (p<.0001 for means, p<0.005 for variances). The figure. Overall differences between the means and variances were significant (p<0.0001).
Respiratory Particle Delivery Rate
The RPDR is shown in Figure 4 . There was a highly significant difference in the means and variances among the groups (p<.0001 for means, p<0.005 for variances. The RPDR varied from 0.03 ml/min (Acorn-II) to 0.28 ml/min (AquaTower). The RPDR for the PARI-JET (0.26 ml/min) and PARI LC JET (0.24 ml/min) did not differ significantly from the AquaTower (0.29ml/min) and the Sidestream (0.19 ml/min). However is presumably due to the increasing contribution of evaporation to the loss of diluent from the nebulizer bowl. While analysis for drug delivery might have varied somewhat from that of particles, the principles of evaporative loss of diluent have been shown to apply to nebulizers of various manufacturers. It is unlikely that this further analysis would have greatly altered the outcome of the study.
In summary, commercially available jet nebulizers, all with the same initial fill, and all driven by the same air compressor, varied greatly in the total delivery of fluid, the time required to deliver this fluid, and the percent of the delivered fluid in the respirable range. This resulted in a variability of total output of twofold, of the time required for nebulization of ninefold, and of drug delivery in the respiratory range per minute of eightfold. These performance characteristics as well as the reproducibility from unit to unit should be considered in selection of a jet nebulizer.14
